Alpha1-antitrypsin single dose adjuvant therapy for acute otitis media

Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 1, 2006, Pages 111-115

  Antonelli, Patrick J ^a   Schultz, Gregory S ^a   Sundin, David J ^b   Pemberton, Philip A ^b   Barr, Philip J ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b Arriva Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; PROTEINASE INHIBITOR;

ACUTE OTITIS MEDIA; ADJUVANT CHEMOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINCHILLA; CONTROLLED STUDY; EARDRUM; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; MALE; NONHUMAN; SCORING SYSTEM; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; TEMPORAL BONE; TREATMENT OUTCOME; TYMPANOMETRY;

ACUTE DISEASE; ALPHA 1-ANTITRYPSIN; ANIMALS; AUDITORY THRESHOLD; CHINCHILLA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME; TRYPSIN INHIBITORS;

EID: 33745444851     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2005.11.050     Document Type: Article

References (22)

1. Juhn S.K., and Huff J.S. Biochemical characteristics of middle ear effusions. Ann Otol Rhinol Laryngol 85 2 Suppl 25 Pt 2 (1976) 110-116
2. Plaut A.G., Qiu J., and St Geme J.W. III Human lactoferrin proteolytic activity. analysis of the cleaved region in the IgA protease of Haemophilus influenzae. Vaccine 8 19 Suppl 1 (2000) S148-S152
3. Hamaguchi Y., and Sakakura Y. Neutrophil elastase and its complex with alpha 1-antitrypsin in the pathogenesis of chronic suppurative otitis media. Ann Otol Rhinol Laryngol Suppl 157 (1992) 26-31
4. Antonelli P.J., Schultz G.S., Kim K.M., et al. Alpha 1-antitrypsin and ilomastat inhibit inflammatory proteases present in human middle ear effusions. Laryngoscope 113 (2003) 1347-1351
5. Antonelli P.J., Schultz G.S., Sundin D.J., et al. Protease inhibitors alpha1-antitrypsin and ilomastat are not ototoxic in the chinchilla. Laryngoscope 113 (2003) 1764-1769
6. Wachter A.M., and Lezdey J. Treatment of atopic dermatitis with alpha 1-proteinase inhibitor. Ann Allergy 69 (1992) 407-414
7. Cotter C.S., Avidano M.A., Stringer S.P., et al. Inhibition of proteases in Pseudomonas otitis media in chinchillas. Otolaryngol Head Neck Surg 115 (1996) 342-351
8. Antonelli P.J., Juhn S.K., Goycoolea M.V., et al. Pseudomonas otitis media after eustachian tube obstruction. Otolaryngol Head Neck Surg 107 (1992) 511-515
9. Yoon T.H., Paparella M.M., Schachern P.A., et al. Morphometric studies of the continuum of otitis media. Ann Otol Rhinol Laryngol Suppl 148 (1990) 23-27
10. Costerton J.W., Stewart P.S., and Greenberg E.P. Bacterial biofilms. a common cause of persistent infections. Science 284 5418 (1999) 1318-1322
11. Kawana M., Kawana C., and Giebink G.S. Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media. Infect Immun 60 (1992) 1908-1912
12. Park S.N., and Yeo S.W. Effects of antibiotics and steroid on middle ear mucosa in rats with experimental acute otitis media. Acta Otolaryngol 121 (2001) 808-812
13. Alper C.M., Dohar J.E., Gulhan M., et al. Treatment of chronic suppurative otitis media with topical tobramycin and dexamethasone. Arch Otolaryngol Head Neck Surg 126 (2000) 165-173
14. Roland P.S., Anon, Moe R.D., et al. Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes. Laryngoscope 113 (2003) 2116-2122
15. Sennaroglu L., Ozkul A., Gedikoglu G., et al. Effect of intratympanic steroid application on the development of experimental cholesteatoma. Laryngoscope 108 (1998) 543-547
16. Jusko W.J., and Rose J.Q. Monitoring prednisone and prednisolone. Ther Drug Monit 2 (1980) 169-176
17. Spandow O., and Hellstrom S. Animal model for persistent tympanic membrane perforations. Ann Otol Rhinol Laryngol 102 (1993) 467-472
18. 1-protease inhibitor. Chest 119 (2001) 737-744
19. Doring G. Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis. Pediatr Pulmonol 28 (1999) 363-375
20. Carlsson B., Lundberg C., and Ohlsson K. Granulocyte protease inhibition in acute and chronic middle ear effusion. Acta Otolaryngol 95 (1983) 341-349
21. Sebert M.E., Palmer L.M., Rosenberg M., et al. Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun 70 (2002) 4059-4067
22. Woods D.E., Cryz S.J., Friedman R.L., et al. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun 36 (1982) 1223-1228